際際滷

際際滷Share a Scribd company logo
DEFINITIONS 
 ANAESTHESIA  This is loss of all forms of sensation 
including pain, touch, temperature and pressure 
sensation which may be accompanied by impairment 
of motor function. 
 ANALGESIA  Loss of pain sensation unaccompanied 
by loss of other forms of sensibility.
IDEAL PROPERTIES OF LA AGENT 
 POTENCY AND RELIABILITY- Should effectively produce 
analgesia when administered in adequate dosage. 
 REVERSIBILITY OF ACTION- Must be completely 
reversible within predictable time. 
 SAFETY- Should not be toxic. 
Therapeutic Lethal dose(LD50) 
ratio = Effective dose(ED50) 
The higher the ratio the greater the safety margin. 
 LACK OF IRRITATION- It should be isotonic with a pH 
compatible to that of the tissues.
IDEAL PROPERTIES- Contd 
 RAPIDITY OF ONSET- Ideally, injection should 
be followed by immediate onset of LA. 
 DURATION OF EFFECT  The effect last till the 
completion of treatment. 
 STERILITY 
 ADEQUATE SHELF LIFE- Average is 2-2.5 years. 
 PENETRATION OF MUCOUS MEMBRANE- It 
should have penetrating ability.
CONSTITUENTS OF LOCAL 
ANAESTHETIC SOLUTIONS 
 Local anaesthetic agent 
 Vasoconstrictor 
 Reducing agent 
 Preservative 
 Fungicide 
 vehicle
 LA AGENT 
 ESTER LINKAGE- e.g. Procaine, Cocaine, 
Tetracaine. 
 AMIDE LINKAGE  e.g. Lignocaine, Prilocaine, 
Mepivacaine, Articaine, Etidocaine, Bupivacaine. 
 Short acting 
3% Mepivacaine (20-40mins) 
4% Prilocaine (5-10mins)
 Long acting 
a) 2% Lidocaine with VC (60mins) 
b) 0.5% Bupivacaine with VC (>90mins) 
c) 1.5% Ethidocaine with VC (>90mins) 
d) 4% Articaine (60mins) 
e) 4% Prilocaine with VC (60-90mins)
CONSTITUENTS OF LA AGENT Contd. 
 VASOCONSTRICTORS 
a. Adrenaline-A synthetic substance similar to 
that secreted in human body 
b. Felypressin- A synthetically produced 
polypeptide similar to that secreted from 
human posterior pituitary gland. It is 
contraindicated in pregnant women because it 
is believed to have an oxytocin-like effect. 
c. Noradrenaline- 
The common concentrations of adrenaline or 
noradrenaline are;1:50,000 1:80,000 1:100,000. 
Felypressin is only available in citanest in a 
concentration of 0.031U/ml.
 Advantages; 
 Reduces toxic effect by retarding the 
absorption of the constituents. 
 By confining the local anaesthetic agent to a 
localised area, it increases the depth and 
duration of anaesthesia. 
 Produces a bloodless field of operation for 
surgical procedures.
DILUTION OF VASOCONSTRICTOR 
 Dilution of vasoconstrictor is commonly 
referred to as a ratio of 1:1000. 
 A conc. Of 1:1000 means that 1gram 
(1000mg) of solute (drug) contained in 1000ml 
of solution. ie 1:1000 dilution contains 
1000mg in 1000ml or 1.0mg/ml of solution.
Maximum safest dose of lidocaine 
adult dose 
 Lidocaine without vasoconstrictor is 300mg 
 Lidocaine with vasoconstrictor is 500mg. 
 2% of lidocaine=20mg/ml 
 ie 20mg=1ml 
 X=1.8ml 
 X=1.8x20 
 X=36mg of lidocaine in one ampule. 
 Number of ampules that can be safely used for 
the pt in one visit=500mg/36, 14mg/ml.
Weight (more accurate) 
 Lidocaine without vasoconstrictor =4.4mg/kg 
 Lidocaine with vasoconstrictor= 7mg/kg
Children dose(clarks rule) 
 Always deals with weight of pt. 
Dose of child=weight of child in 
pounds/150adult dose. 
Youngs rule 
 Always deals with age of pt. 
 Age of pt  adult dose/age of pt12
Healthy patient 
 0.2mg of epinephrine 
 In pt with cardiac problem=0.04mg
 REDUCING AGENT 
 Sodium bimetasulphite in small quantity is 
included in the solution to prevents oxidation of 
the vasoconstrictors as they are unstable in 
solution, especialy on exposure to sunlight.
CONSTITUENTS Contd. 
 PRESERVATIVE 
 Caprylhydrocupreinotoxin in xylotox helps to 
maintain sterility of the solution and also 
increases its shelf life. 
 FUNGICIDE 
 Thymol prevents proliferation of minute fungae 
which cause cloudiness of the solution.
 VEHICLE 
 Ringers solution(modified) is an isotonic solution 
in which all the other constituents are dissolved 
to minimize discomfort during injection of the 
LA.
MODE OF ACTION 
 LA agent is made up of a weak base and strong 
acid which is hydrolyzed in the alkaline medium 
of human tissues to liberate the alkaloid base. 
 This stabilizes the axonal limiting membrane of 
the nerve fibres thereby preventing the inflow of 
sodium ions into the cell and the resultant 
depolarization of the cell membrane. 
 Impulse conduction is thus prevented so that 
pain stimulus is not transmitted.
Tips for painless injection 
Control 
Communication 
Confidence 
slow injection[slower still in tense tissue] 
Pre-anesthesia 
Needle insertion[sharp &slow] 
Distraction 
Small guage needles 
Solution warming
METHOD OF LA ADMIN 
 TOPICAL 
 Suitable LA is applied either to an area of skin or 
mucous membrane which it penetrates to act at the 
superficial nerve endings. 
 Sprays : 10% Lignocaine HCl 
 Ointment : 5% Lignocaine HCl 
 Emulsion : 2% Lignocaine HCl
 INFILTRATION 
 Submucous injection : the solution is deposited 
just beneath the mucous membrane. This method 
is used for anaesthetizing the long buccal nerve. 
 Sub-periosteal injection: The solution is deposited 
between periosteum and cortical plate of bone. 
E.g in palate.
 Supra-periosteal injection: The solution is deposited 
outside the periosteum. Most frequently used in the 
maxilla where the cortical plate of the alveolar bone 
is thin and perforated by tiny vascular canals.
METHOD CONTD 
 Intraosseous-The solution is deposited within the 
medullary bone. 
 Intraseptal- The solution is deposited into the soft 
bone of the alveolar crest.
 REGIONAL BLOCK 
 This is deposited near the nerve trunk and blocks 
the areas supplied by the nerve trunk. It is reliable 
in the mandible due to the thickness of the bone.
LA IN MAXILLA 
MAXILLARY 
Posterior superior alveolar nerve block: 
The upper 3rd,2nd and the distobuccal and palatal 
roots of the 1st molar are innervated by posterior 
superior alveolar nerve. 
 LA is deposited between the 2nd and 3rd molars. 
Serves the three maxillary molars and related 
buccal soft tissue (except the MB root of 1st 
molar).
METHODS Contd. 
 Anterior and middle superior alveolar nerve 
 The mesiobuccal root of the 1st molar, both 
pre molars are supplied by this nerve. 
 LA is deposited just above the upper limit of 
the attached gingivae with the needle in-line 
with the long axis of the tooth. Serves 
premolars, all anterior teeth and overlying 
buccal mucosa and bone.
LA IN MAX CONTD 
 GREATER PALATINE NERVE  This is given over the 
estimated area of the apex of the root and should 
never be deposited distal to the 2nd molar because it 
will produce anaesthesia of the soft palate and 
uvular area making swallowing difficult for the 
patient. 
NASOPALATINE NERVE  This is deposited beneath 
the incisive papilla at a site lateral to central rugae 
and deposited slowly to reduce discomfort. Provides 
anaesthesia of hard and soft tissue of the pre maxilla 
as far as the distal aspect of the 1st premolar.
LA IN MANDIBLE 
 Due to the density of the buccal plate of bone 
infilteration technics are of limited value in the 
mandible and regional or block anaesthesia is 
most frequently used. E g inferior alveolar nerve 
block is done in the pterygomandibular space. 
PTERYGOMANDIBULAR SPACE Anaesthesia in the 
mandible is achieved by deposition of the 
solution around the inferior alveolar and lingual 
nerve in the pterygo-mandibular space.
Ad

Recommended

Local anaesthesia- composition and dosage in dentistry
Local anaesthesia- composition and dosage in dentistry
Vikram Perakath
Local Anesthesia - Paedodontics
Local Anesthesia - Paedodontics
Dr Reem Ayesha
Local anaesthesia _pedo_
Local anaesthesia _pedo_
Moola Reddy
Anaesthetic Techniques
Anaesthetic Techniques
Urfeya Mirza
Local anesthesia in animals
Local anesthesia in animals
DR AMEER HAMZA
Local anasthesia in dentistry
Local anasthesia in dentistry
Mohammed Rhael
Local Anaesthesia In Plastic Surgery
Local Anaesthesia In Plastic Surgery
Dr Saurabh Garg
Pain control in oral surgery
Pain control in oral surgery
wria zangana
LOCAL ANESTHESIA IN ORAL AND MAXILLOFACIAL SURGERY
LOCAL ANESTHESIA IN ORAL AND MAXILLOFACIAL SURGERY
ARSHIYAGARG1
la-141122030742-conversion-gate01.pdf
la-141122030742-conversion-gate01.pdf
HaroonButt17
Local anaesthesia in dentistry
Local anaesthesia in dentistry
KirtiRanka1
local anaesthesia used in dentistery ppt
local anaesthesia used in dentistery ppt
htetmyat553419
Localans 140906145706-phpapp02-160924162017
Localans 140906145706-phpapp02-160924162017
Maryam Arbab
Techniques of regional anesthesia
Techniques of regional anesthesia
Dr. SHEETAL KAPSE
Local anaesthesia
Local anaesthesia
Mohammed Haneef Farooq
Local Anesthesia for pediatric dentistry
Local Anesthesia for pediatric dentistry
Rahaf Sn
Local anaesthesia and techniques for pedodontics
Local anaesthesia and techniques for pedodontics
komal0506
Long Island Periodontist presents "The Art and Science of the Painless Dental...
Long Island Periodontist presents "The Art and Science of the Painless Dental...
Edward Brant DDS, MS
Local anesthesia IN PERIODONTICS DR.ANIZ.pptx
Local anesthesia IN PERIODONTICS DR.ANIZ.pptx
PrasanthThalur
local anesthetic.ppt
local anesthetic.ppt
muhammadmansooralamk1
Local anaesthetics Dr.Vrushali
Local anaesthetics Dr.Vrushali
vrushali83
Pharmacotherapy of Local anaesthetic drugs
Pharmacotherapy of Local anaesthetic drugs
Manoj Kumar
Local anesthesia in children
Local anesthesia in children
Dr. Nameeda K. S.
LOCAL ANESTHESIA.pptx
LOCAL ANESTHESIA.pptx
alpeshbista1
local anesthesia: Uses, Types, Side effects and Safety
local anesthesia: Uses, Types, Side effects and Safety
PrachiRathi40
Local Anasthesia
Local Anasthesia
Rajvi Nahar
Local anaesthetics
Local anaesthetics
John Milton
Maxillary injection techniques
Maxillary injection techniques
Nishant Khurana
State of the Art LVAD Care: What Does the Year 2025 Bring?
State of the Art LVAD Care: What Does the Year 2025 Bring?
Duke Heart
Drugs Acting on the Autonomic Nervous System Classification, Properties & Uses
Drugs Acting on the Autonomic Nervous System Classification, Properties & Uses
Sajini

More Related Content

Similar to La (20)

LOCAL ANESTHESIA IN ORAL AND MAXILLOFACIAL SURGERY
LOCAL ANESTHESIA IN ORAL AND MAXILLOFACIAL SURGERY
ARSHIYAGARG1
la-141122030742-conversion-gate01.pdf
la-141122030742-conversion-gate01.pdf
HaroonButt17
Local anaesthesia in dentistry
Local anaesthesia in dentistry
KirtiRanka1
local anaesthesia used in dentistery ppt
local anaesthesia used in dentistery ppt
htetmyat553419
Localans 140906145706-phpapp02-160924162017
Localans 140906145706-phpapp02-160924162017
Maryam Arbab
Techniques of regional anesthesia
Techniques of regional anesthesia
Dr. SHEETAL KAPSE
Local anaesthesia
Local anaesthesia
Mohammed Haneef Farooq
Local Anesthesia for pediatric dentistry
Local Anesthesia for pediatric dentistry
Rahaf Sn
Local anaesthesia and techniques for pedodontics
Local anaesthesia and techniques for pedodontics
komal0506
Long Island Periodontist presents "The Art and Science of the Painless Dental...
Long Island Periodontist presents "The Art and Science of the Painless Dental...
Edward Brant DDS, MS
Local anesthesia IN PERIODONTICS DR.ANIZ.pptx
Local anesthesia IN PERIODONTICS DR.ANIZ.pptx
PrasanthThalur
local anesthetic.ppt
local anesthetic.ppt
muhammadmansooralamk1
Local anaesthetics Dr.Vrushali
Local anaesthetics Dr.Vrushali
vrushali83
Pharmacotherapy of Local anaesthetic drugs
Pharmacotherapy of Local anaesthetic drugs
Manoj Kumar
Local anesthesia in children
Local anesthesia in children
Dr. Nameeda K. S.
LOCAL ANESTHESIA.pptx
LOCAL ANESTHESIA.pptx
alpeshbista1
local anesthesia: Uses, Types, Side effects and Safety
local anesthesia: Uses, Types, Side effects and Safety
PrachiRathi40
Local Anasthesia
Local Anasthesia
Rajvi Nahar
Local anaesthetics
Local anaesthetics
John Milton
Maxillary injection techniques
Maxillary injection techniques
Nishant Khurana
LOCAL ANESTHESIA IN ORAL AND MAXILLOFACIAL SURGERY
LOCAL ANESTHESIA IN ORAL AND MAXILLOFACIAL SURGERY
ARSHIYAGARG1
la-141122030742-conversion-gate01.pdf
la-141122030742-conversion-gate01.pdf
HaroonButt17
Local anaesthesia in dentistry
Local anaesthesia in dentistry
KirtiRanka1
local anaesthesia used in dentistery ppt
local anaesthesia used in dentistery ppt
htetmyat553419
Localans 140906145706-phpapp02-160924162017
Localans 140906145706-phpapp02-160924162017
Maryam Arbab
Techniques of regional anesthesia
Techniques of regional anesthesia
Dr. SHEETAL KAPSE
Local Anesthesia for pediatric dentistry
Local Anesthesia for pediatric dentistry
Rahaf Sn
Local anaesthesia and techniques for pedodontics
Local anaesthesia and techniques for pedodontics
komal0506
Long Island Periodontist presents "The Art and Science of the Painless Dental...
Long Island Periodontist presents "The Art and Science of the Painless Dental...
Edward Brant DDS, MS
Local anesthesia IN PERIODONTICS DR.ANIZ.pptx
Local anesthesia IN PERIODONTICS DR.ANIZ.pptx
PrasanthThalur
Local anaesthetics Dr.Vrushali
Local anaesthetics Dr.Vrushali
vrushali83
Pharmacotherapy of Local anaesthetic drugs
Pharmacotherapy of Local anaesthetic drugs
Manoj Kumar
Local anesthesia in children
Local anesthesia in children
Dr. Nameeda K. S.
LOCAL ANESTHESIA.pptx
LOCAL ANESTHESIA.pptx
alpeshbista1
local anesthesia: Uses, Types, Side effects and Safety
local anesthesia: Uses, Types, Side effects and Safety
PrachiRathi40
Local Anasthesia
Local Anasthesia
Rajvi Nahar
Local anaesthetics
Local anaesthetics
John Milton
Maxillary injection techniques
Maxillary injection techniques
Nishant Khurana

Recently uploaded (20)

State of the Art LVAD Care: What Does the Year 2025 Bring?
State of the Art LVAD Care: What Does the Year 2025 Bring?
Duke Heart
Drugs Acting on the Autonomic Nervous System Classification, Properties & Uses
Drugs Acting on the Autonomic Nervous System Classification, Properties & Uses
Sajini
COUGH AND THIER DRUGS AND MODE OF ACTION.pptx
COUGH AND THIER DRUGS AND MODE OF ACTION.pptx
PackialakshmiP
ELECTROMYOGRAPHY.pptX by GOKULAKRISHNAN.
ELECTROMYOGRAPHY.pptX by GOKULAKRISHNAN.
GOKULAKRISHNAN JANARTHANAN
Theories of Learning and Teaching.......
Theories of Learning and Teaching.......
Avantika Gupta
Aspirin powder or Acetyl salicylic acid powder.docx
Aspirin powder or Acetyl salicylic acid powder.docx
kopalsharma85
Peripheral Retinal Degenerations. pptxxx
Peripheral Retinal Degenerations. pptxxx
Dr. Geetika Singh
GAIT in Biomechanics along with abnormal gait
GAIT in Biomechanics along with abnormal gait
Nerusu sai priyanka
When is the Right Time to Refer to (Advanced) Heart Failure?
When is the Right Time to Refer to (Advanced) Heart Failure?
Duke Heart
Best Practices in Heart Failure Transitional Care
Best Practices in Heart Failure Transitional Care
Duke Heart
THE EYELID PPT FOR 1ST YEAR BSC OPTOMETRY
THE EYELID PPT FOR 1ST YEAR BSC OPTOMETRY
nihalanichz
Ophthalmic Techniques HSSC-1 | Federal Board Past Paper | 2025 Preparation.pdf
Ophthalmic Techniques HSSC-1 | Federal Board Past Paper | 2025 Preparation.pdf
azkaimran130
whooping cough community health nursing.
whooping cough community health nursing.
ASWIN S
Devices in the Management of Acute Heart Failure (or) Cardiogenic Shock
Devices in the Management of Acute Heart Failure (or) Cardiogenic Shock
Duke Heart
Exomind in General Aesthetics - with June 10, 2025 updates
Exomind in General Aesthetics - with June 10, 2025 updates
lcadymd1
management trauma abdominal injury of abdominal trauma
management trauma abdominal injury of abdominal trauma
furqanfries1
Quality of Life in CHF & Patient Preferences
Quality of Life in CHF & Patient Preferences
Duke Heart
Multidisciplinary Strategies in GDMT Implementation
Multidisciplinary Strategies in GDMT Implementation
Duke Heart
Guideline Directed Medical Therapy: What is the Best Approach?
Guideline Directed Medical Therapy: What is the Best Approach?
Duke Heart
5-Lift Analysis in ergonomics focuses on evaluating the safety and efficienc...
5-Lift Analysis in ergonomics focuses on evaluating the safety and efficienc...
Bolan University of Medical and Health Sciences ,Quetta
State of the Art LVAD Care: What Does the Year 2025 Bring?
State of the Art LVAD Care: What Does the Year 2025 Bring?
Duke Heart
Drugs Acting on the Autonomic Nervous System Classification, Properties & Uses
Drugs Acting on the Autonomic Nervous System Classification, Properties & Uses
Sajini
COUGH AND THIER DRUGS AND MODE OF ACTION.pptx
COUGH AND THIER DRUGS AND MODE OF ACTION.pptx
PackialakshmiP
Theories of Learning and Teaching.......
Theories of Learning and Teaching.......
Avantika Gupta
Aspirin powder or Acetyl salicylic acid powder.docx
Aspirin powder or Acetyl salicylic acid powder.docx
kopalsharma85
Peripheral Retinal Degenerations. pptxxx
Peripheral Retinal Degenerations. pptxxx
Dr. Geetika Singh
GAIT in Biomechanics along with abnormal gait
GAIT in Biomechanics along with abnormal gait
Nerusu sai priyanka
When is the Right Time to Refer to (Advanced) Heart Failure?
When is the Right Time to Refer to (Advanced) Heart Failure?
Duke Heart
Best Practices in Heart Failure Transitional Care
Best Practices in Heart Failure Transitional Care
Duke Heart
THE EYELID PPT FOR 1ST YEAR BSC OPTOMETRY
THE EYELID PPT FOR 1ST YEAR BSC OPTOMETRY
nihalanichz
Ophthalmic Techniques HSSC-1 | Federal Board Past Paper | 2025 Preparation.pdf
Ophthalmic Techniques HSSC-1 | Federal Board Past Paper | 2025 Preparation.pdf
azkaimran130
whooping cough community health nursing.
whooping cough community health nursing.
ASWIN S
Devices in the Management of Acute Heart Failure (or) Cardiogenic Shock
Devices in the Management of Acute Heart Failure (or) Cardiogenic Shock
Duke Heart
Exomind in General Aesthetics - with June 10, 2025 updates
Exomind in General Aesthetics - with June 10, 2025 updates
lcadymd1
management trauma abdominal injury of abdominal trauma
management trauma abdominal injury of abdominal trauma
furqanfries1
Quality of Life in CHF & Patient Preferences
Quality of Life in CHF & Patient Preferences
Duke Heart
Multidisciplinary Strategies in GDMT Implementation
Multidisciplinary Strategies in GDMT Implementation
Duke Heart
Guideline Directed Medical Therapy: What is the Best Approach?
Guideline Directed Medical Therapy: What is the Best Approach?
Duke Heart
Ad

La

  • 1. DEFINITIONS ANAESTHESIA This is loss of all forms of sensation including pain, touch, temperature and pressure sensation which may be accompanied by impairment of motor function. ANALGESIA Loss of pain sensation unaccompanied by loss of other forms of sensibility.
  • 2. IDEAL PROPERTIES OF LA AGENT POTENCY AND RELIABILITY- Should effectively produce analgesia when administered in adequate dosage. REVERSIBILITY OF ACTION- Must be completely reversible within predictable time. SAFETY- Should not be toxic. Therapeutic Lethal dose(LD50) ratio = Effective dose(ED50) The higher the ratio the greater the safety margin. LACK OF IRRITATION- It should be isotonic with a pH compatible to that of the tissues.
  • 3. IDEAL PROPERTIES- Contd RAPIDITY OF ONSET- Ideally, injection should be followed by immediate onset of LA. DURATION OF EFFECT The effect last till the completion of treatment. STERILITY ADEQUATE SHELF LIFE- Average is 2-2.5 years. PENETRATION OF MUCOUS MEMBRANE- It should have penetrating ability.
  • 4. CONSTITUENTS OF LOCAL ANAESTHETIC SOLUTIONS Local anaesthetic agent Vasoconstrictor Reducing agent Preservative Fungicide vehicle
  • 5. LA AGENT ESTER LINKAGE- e.g. Procaine, Cocaine, Tetracaine. AMIDE LINKAGE e.g. Lignocaine, Prilocaine, Mepivacaine, Articaine, Etidocaine, Bupivacaine. Short acting 3% Mepivacaine (20-40mins) 4% Prilocaine (5-10mins)
  • 6. Long acting a) 2% Lidocaine with VC (60mins) b) 0.5% Bupivacaine with VC (>90mins) c) 1.5% Ethidocaine with VC (>90mins) d) 4% Articaine (60mins) e) 4% Prilocaine with VC (60-90mins)
  • 7. CONSTITUENTS OF LA AGENT Contd. VASOCONSTRICTORS a. Adrenaline-A synthetic substance similar to that secreted in human body b. Felypressin- A synthetically produced polypeptide similar to that secreted from human posterior pituitary gland. It is contraindicated in pregnant women because it is believed to have an oxytocin-like effect. c. Noradrenaline- The common concentrations of adrenaline or noradrenaline are;1:50,000 1:80,000 1:100,000. Felypressin is only available in citanest in a concentration of 0.031U/ml.
  • 8. Advantages; Reduces toxic effect by retarding the absorption of the constituents. By confining the local anaesthetic agent to a localised area, it increases the depth and duration of anaesthesia. Produces a bloodless field of operation for surgical procedures.
  • 9. DILUTION OF VASOCONSTRICTOR Dilution of vasoconstrictor is commonly referred to as a ratio of 1:1000. A conc. Of 1:1000 means that 1gram (1000mg) of solute (drug) contained in 1000ml of solution. ie 1:1000 dilution contains 1000mg in 1000ml or 1.0mg/ml of solution.
  • 10. Maximum safest dose of lidocaine adult dose Lidocaine without vasoconstrictor is 300mg Lidocaine with vasoconstrictor is 500mg. 2% of lidocaine=20mg/ml ie 20mg=1ml X=1.8ml X=1.8x20 X=36mg of lidocaine in one ampule. Number of ampules that can be safely used for the pt in one visit=500mg/36, 14mg/ml.
  • 11. Weight (more accurate) Lidocaine without vasoconstrictor =4.4mg/kg Lidocaine with vasoconstrictor= 7mg/kg
  • 12. Children dose(clarks rule) Always deals with weight of pt. Dose of child=weight of child in pounds/150adult dose. Youngs rule Always deals with age of pt. Age of pt adult dose/age of pt12
  • 13. Healthy patient 0.2mg of epinephrine In pt with cardiac problem=0.04mg
  • 14. REDUCING AGENT Sodium bimetasulphite in small quantity is included in the solution to prevents oxidation of the vasoconstrictors as they are unstable in solution, especialy on exposure to sunlight.
  • 15. CONSTITUENTS Contd. PRESERVATIVE Caprylhydrocupreinotoxin in xylotox helps to maintain sterility of the solution and also increases its shelf life. FUNGICIDE Thymol prevents proliferation of minute fungae which cause cloudiness of the solution.
  • 16. VEHICLE Ringers solution(modified) is an isotonic solution in which all the other constituents are dissolved to minimize discomfort during injection of the LA.
  • 17. MODE OF ACTION LA agent is made up of a weak base and strong acid which is hydrolyzed in the alkaline medium of human tissues to liberate the alkaloid base. This stabilizes the axonal limiting membrane of the nerve fibres thereby preventing the inflow of sodium ions into the cell and the resultant depolarization of the cell membrane. Impulse conduction is thus prevented so that pain stimulus is not transmitted.
  • 18. Tips for painless injection Control Communication Confidence slow injection[slower still in tense tissue] Pre-anesthesia Needle insertion[sharp &slow] Distraction Small guage needles Solution warming
  • 19. METHOD OF LA ADMIN TOPICAL Suitable LA is applied either to an area of skin or mucous membrane which it penetrates to act at the superficial nerve endings. Sprays : 10% Lignocaine HCl Ointment : 5% Lignocaine HCl Emulsion : 2% Lignocaine HCl
  • 20. INFILTRATION Submucous injection : the solution is deposited just beneath the mucous membrane. This method is used for anaesthetizing the long buccal nerve. Sub-periosteal injection: The solution is deposited between periosteum and cortical plate of bone. E.g in palate.
  • 21. Supra-periosteal injection: The solution is deposited outside the periosteum. Most frequently used in the maxilla where the cortical plate of the alveolar bone is thin and perforated by tiny vascular canals.
  • 22. METHOD CONTD Intraosseous-The solution is deposited within the medullary bone. Intraseptal- The solution is deposited into the soft bone of the alveolar crest.
  • 23. REGIONAL BLOCK This is deposited near the nerve trunk and blocks the areas supplied by the nerve trunk. It is reliable in the mandible due to the thickness of the bone.
  • 24. LA IN MAXILLA MAXILLARY Posterior superior alveolar nerve block: The upper 3rd,2nd and the distobuccal and palatal roots of the 1st molar are innervated by posterior superior alveolar nerve. LA is deposited between the 2nd and 3rd molars. Serves the three maxillary molars and related buccal soft tissue (except the MB root of 1st molar).
  • 25. METHODS Contd. Anterior and middle superior alveolar nerve The mesiobuccal root of the 1st molar, both pre molars are supplied by this nerve. LA is deposited just above the upper limit of the attached gingivae with the needle in-line with the long axis of the tooth. Serves premolars, all anterior teeth and overlying buccal mucosa and bone.
  • 26. LA IN MAX CONTD GREATER PALATINE NERVE This is given over the estimated area of the apex of the root and should never be deposited distal to the 2nd molar because it will produce anaesthesia of the soft palate and uvular area making swallowing difficult for the patient. NASOPALATINE NERVE This is deposited beneath the incisive papilla at a site lateral to central rugae and deposited slowly to reduce discomfort. Provides anaesthesia of hard and soft tissue of the pre maxilla as far as the distal aspect of the 1st premolar.
  • 27. LA IN MANDIBLE Due to the density of the buccal plate of bone infilteration technics are of limited value in the mandible and regional or block anaesthesia is most frequently used. E g inferior alveolar nerve block is done in the pterygomandibular space. PTERYGOMANDIBULAR SPACE Anaesthesia in the mandible is achieved by deposition of the solution around the inferior alveolar and lingual nerve in the pterygo-mandibular space.